NCT04298515

Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

Determination of the Relationship Between Nesfatin-1 Levels and Energy Intake Levels of Patients With Type 2 Diabetes, Insulin Resistance and Obesity

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Istanbul Medeniyet University · Academic / Other
• Sex: All
• Age: 19 Years – 79 Years
• Healthy volunteers: Accepted

Summary

This research was planned to determine the level of nesfatin-1, known as satiety hormone, in type 2 diabetes, insulin diabetes and obesity patients and to determine whether there is a relationship between patients' energy intake levels. Additionally, it was aimed to evaluate the relationship between patients' nesfatin-1 values and serum glucose, insulin, lipid concentrations.

Detailed description

Nesfatin-1 levels of patients with type 2 diabetes, insulin resistance and obesity will be measured. In addition, patients' daily food consumption will be taken and the amount of energy they receive will be calculated daily. The relationship between the level of nesfatin-1 in the blood and the energy received will be examined.

Conditions

• Type 2 Diabetes
• Insulin Resistance
• Obesity
• Nesfatin-1

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Nesfatin-1	Blood will be taken from the patients on an empty stomach for measuring nesfatin-1 level

Timeline

• Start date: 2020-03-02
• Primary completion: 2021-03-31
• Completion: 2021-03-31
• First posted: 2020-03-06
• Last updated: 2020-03-06

Locations

1 site across 1 country: Turkey (Türkiye)